These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10198765)
1. [The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, liposomes with L-DOPA and "empty" liposomes on the phospholipid composition of the murine liver]. Podgornyĭ GN; Namestnikova IV; Sliusar' NN Eksp Klin Farmakol; 1999; 62(1):41-4. PubMed ID: 10198765 [TBL] [Abstract][Full Text] [Related]
2. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related]
3. [The effect of prolonged parenteral administration of liposomes and L-Dopa incorporated into liposomes on metabolism of dopamine and its metabolites in the striatum of mice with experimental parkinsonian syndrome]. Iurasov VV; Kucherianu VG; Kudrin VS; Zhigal'tsev IV; Nikushkin EV; Sandalov IuG; Kaplun AP; Shvets VI Biull Eksp Biol Med; 1997 Feb; 123(2):150-3. PubMed ID: 9280483 [No Abstract] [Full Text] [Related]
4. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490 [TBL] [Abstract][Full Text] [Related]
5. [The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome]. Iurasov VV; Podgornyĭ GI; Kucherianu VG; Kudrin VS; Nikushkin EV; Zhigal'tsev IV; Sandalov IuG; Kaplun AP; Shvets VI; Kryzhanovskiĭ GN Biull Eksp Biol Med; 1996 Dec; 122(12):614-7. PubMed ID: 9280455 [No Abstract] [Full Text] [Related]
6. Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets. Jackson MJ; Smith LA; Al-Barghouthy G; Rose S; Jenner P Exp Neurol; 2007 Mar; 204(1):162-70. PubMed ID: 17113078 [TBL] [Abstract][Full Text] [Related]
7. Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Nicholas AP Mov Disord; 2007 Jan; 22(1):99-104. PubMed ID: 17133519 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY; Park HJ; Ahn YH; Lee PH J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187 [TBL] [Abstract][Full Text] [Related]
9. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Chalimoniuk M; Langfort J Neurochem Int; 2007 May; 50(6):821-33. PubMed ID: 17379358 [TBL] [Abstract][Full Text] [Related]
10. [Effect of phosphatidylcholine liposomes on lipid peroxidation in the liver and phospholipid metabolism in hepatocyte plasma membrane in hemorrhagic shock]. Leskova GF; Udovichenko VI Patol Fiziol Eksp Ter; 1991; (6):46-7. PubMed ID: 1818288 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice. Mitsumoto Y; Mori A; Ohashi S; Nakai M; Moriizumi T Neurosci Res; 2005 Jan; 51(1):111-5. PubMed ID: 15596247 [TBL] [Abstract][Full Text] [Related]
12. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors. Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115 [TBL] [Abstract][Full Text] [Related]
13. Strain-specific sensitivity to MPTP of C57BL/6 and BALB/c mice is age dependent. Filipov NM; Norwood AB; Sistrunk SC Neuroreport; 2009 May; 20(7):713-7. PubMed ID: 19349914 [TBL] [Abstract][Full Text] [Related]
14. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325 [TBL] [Abstract][Full Text] [Related]
17. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Chen LW; Hu HJ; Liu HL; Yung KK; Chan YS Neuroscience; 2004; 126(4):941-53. PubMed ID: 15207328 [TBL] [Abstract][Full Text] [Related]
18. Selective alterations of gene expression in mice induced by MPTP. Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605 [TBL] [Abstract][Full Text] [Related]
19. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033 [TBL] [Abstract][Full Text] [Related]
20. [Lipid peroxidation and the phospholipid composition of the liver plasma membranes in rabbits in traumatic shock and their pharmacological correction]. Kufterin SM; Udovichenko VI Patol Fiziol Eksp Ter; 1990; (1):17-9. PubMed ID: 2352772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]